Popular:
Astrana Health, Inc. (ASTH)
Intrinsic Value
DCF Not Suitable for ASTH
Low operating margin (2.1%) — business model may not support stable cash flows.
Alternative Approach:
Monitor for margin expansion before applying DCF.
Astrana Health, Inc. (ASTH) Intrinsic Value
DCF-based fair value calculation with Bear, Base, and Bull scenarios
Frequently Asked Questions
Is ASTH stock undervalued or overvalued?
Insufficient data to compute DCF valuation for ASTH. This typically occurs with negative FCF, early-stage companies, or financials where standard DCF models require modification.
What is ASTH's intrinsic value?
Unable to calculate intrinsic value. DCF requires positive free cash flow and complete financial data. For banks/REITs, we substitute Net Income or FFO respectively.
How is ASTH's fair value calculated?
Standard two-stage DCF with 5-year explicit forecast period and Gordon Growth terminal value. WACC estimated from sector averages and company beta. For ASTH, insufficient data prevents full calculation—typically requires 3+ years of positive FCF history.